Are compounded peptides legal and safe? What the science shows

What did @rohammmmm actually say?

The creator made three broad arguments: the COVID vaccines had no trials or safety testing, that peptides like thymosin alpha-1 and methylene blue fix vaccine-related mitochondrial damage, and that FDA approval is not the standard by which you should judge a treatment's safety or legitimacy.

To be fair, the video does include a reasonable caveat: "there is still risks to it, there are stuff you should consider." That kind of honesty is not nothing. But it gets buried under some factually shaky claims that deserve a harder look, especially the vaccine characterization and the mitochondrial damage framing.

Methylene blue being called "an industrial fabric dye" is also a fun rhetorical move. Technically true in some contexts, but it was used in medicine before most people's grandparents were born, including as an antimalarial and a treatment for methemoglobinemia. The framing implies it's some kind of outsider compound, which is misleading.

Does the science back this up?

On the COVID vaccine claim, no, not really. The mRNA vaccines went through Phase 1, 2, and 3 trials before emergency use authorization. That's documented. Pfizer's Phase 3 trial enrolled over 43,000 participants (Polack et al., 2020, New England Journal of Medicine). Emergency authorization is not the same as no trials.

On myocarditis and cardiovascular signals, yes, those are real and documented, particularly in young males after the second mRNA dose. That part of the creator's point has some grounding. The CDC's Vaccine Safety Datalink and studies like Oster et al. (2022, JAMA) confirmed elevated myocarditis risk in that subgroup. But "no testing and no understanding" is a stretch that oversimplifies what actually happened.

On thymosin alpha-1 specifically, there is a real body of research. It has been studied as an immune modulator, with clinical use in some countries for hepatitis B and C and as an adjunct in cancer therapy (Tuthill et al., 2006, Expert Opinion on Biological Therapy). It is not FDA-approved in the US for general use, but calling it completely unstudied is wrong.

Methylene blue and mitochondrial function have been explored in research contexts. Atamna and Kumar (2010, Biochimica et Biophysica Acta) found it can enhance cytochrome c oxidase activity in vitro, suggesting some mitochondrial effects. But the leap from lab findings to "fixes vaccine mitochondrial damage" in humans is enormous and not supported by current clinical evidence.

What did they get wrong (or right)?

Let's be direct. The claim that COVID vaccines had "no trials, no testing and no understanding of the side effects" is inaccurate. It conflates emergency use authorization with a total absence of evaluation. That is a meaningful distinction, and blurring it spreads misinformation even if the creator's underlying skepticism of regulatory bodies has some legitimate basis.

The "mitochondrial damage" framing attributed to the COVID vaccine is also unsubstantiated at a population level. There are hypotheses and case reports in the literature, but no large-scale peer-reviewed evidence establishing this as a confirmed widespread outcome.

Where the creator deserves credit: the point that FDA approval does not equal safety perfection, and that non-approval does not equal dangerous, is a nuanced argument that many researchers and clinicians would actually agree with. Drugs get approved with serious risks. Compounds get used off-label for decades with good outcomes. That part of the argument is not wrong, it's just incomplete without context.

Also correct: thymosin alpha-1 has genuine immune-modulating research behind it. Dismissing it as fringe would itself be inaccurate.

What should you actually know?

If you are considering peptides for any health reason, the lack of FDA approval matters, not because the FDA is infallible, but because approval requires consistent manufacturing standards, defined dosing safety data, and documented adverse event profiles. Compounded peptides vary in purity and concentration depending on the pharmacy. That variability is a real risk, not a theoretical one.

Thymosin alpha-1 has the strongest legitimate research base of the peptides mentioned here. Methylene blue has a long pharmacological history and some intriguing mitochondrial research, but using it to "fix" a specific vaccine injury is a claim that far outpaces the available evidence.

The creator is right that peptides present a "double-edged sword." Self-administering compounds without clinical oversight, regardless of legal status, carries risks that are not offset by forum posts or TikTok videos, including this one being fact-checked. If you are curious about peptide therapy, that conversation belongs in a clinical setting with someone who has access to your full health history.

One more thing: methylene blue is not a peptide. It is a synthetic compound. Grouping it with thymosin alpha-1 and calling them both peptides is a category error worth noting.